HEADER OXIDOREDUCTASE 05-APR-07 2PFX TITLE CRYSTAL STRUCTURE OF UNCHARACTERIZED PEROXIDASE-RELATED PROTEIN TITLE 2 (YP_614459.1) FROM SILICIBACTER SP. TM1040 AT 1.70 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED PEROXIDASE-RELATED PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SILICIBACTER SP.; SOURCE 3 ORGANISM_TAXID: 292414; SOURCE 4 STRAIN: TM1040; SOURCE 5 GENE: YP_614459.1, TM1040_2465; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS YP_614459.1, UNCHARACTERIZED PEROXIDASE-RELATED PROTEIN, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 25-JAN-23 2PFX 1 REMARK SEQADV LINK REVDAT 5 25-OCT-17 2PFX 1 REMARK REVDAT 4 18-OCT-17 2PFX 1 REMARK REVDAT 3 13-JUL-11 2PFX 1 VERSN REVDAT 2 24-FEB-09 2PFX 1 VERSN REVDAT 1 17-APR-07 2PFX 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF UNCHARACTERIZED PEROXIDASE-RELATED JRNL TITL 2 PROTEIN (YP_614459.1) FROM SILICIBACTER SP. TM1040 AT 1.70 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM EXPANDED BY TWIN LAW REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.117 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.114 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.165 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2281 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 49885 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.110 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.108 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.158 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2073 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 45301 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2977 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 315 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3307.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2887.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 13529 REMARK 3 NUMBER OF RESTRAINTS : 13579 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 ANGLE DISTANCES (A) : 0.027 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.065 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.026 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.050 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.049 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.024 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.026 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. 3. ACETATE (ACT) MOLECULES, CL ION AND REMARK 3 TETRAETHYLENE GLYCOL (PG4) FROM THE CRYSTALLIZATION WERE MODELED REMARK 3 INTO THE STRUCTURE. 4. THE SHELXL WAS USED FOR REFINEMENT WITH REMARK 3 THE TWIN LAW K,H,-L AND A REFINED TWIN FRACTION OF 0.35. 5. THE REMARK 3 R-FREE SET WAS GENERATED WITH THE TWIN LAW. 6. REFINEMENT WAS REMARK 3 AGAINST INTENSITY DATA. REMARK 4 REMARK 4 2PFX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-APR-07. REMARK 100 THE DEPOSITION ID IS D_1000042333. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97908, 0.97929 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47633 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 27.842 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.11300 REMARK 200 R SYM (I) : 0.11300 REMARK 200 FOR THE DATA SET : 5.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.43700 REMARK 200 R SYM FOR SHELL (I) : 0.43700 REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 0.1M NACL, 30.0% PEG 200, REMARK 280 0.1M ACETATE PH 4.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K, PH 4.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 52.80800 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 52.80800 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 52.80800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY WITH STATIC LIGHT SCATTERING REMARK 300 SUPPORTS THE ASSIGNMENT OF THE HEXAMER AS A SIGNIFICANT REMARK 300 OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 22310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -146.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 127.60350 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 73.67192 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 147.34383 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 2 OG1 CG2 REMARK 470 LYS A 3 CG CD CE NZ REMARK 470 ASP A 16 CG OD1 OD2 REMARK 470 THR B 2 OG1 CG2 REMARK 470 LYS B 3 CD CE NZ REMARK 470 ASP B 16 CG OD1 OD2 REMARK 470 LYS B 24 CE NZ REMARK 470 GLU B 48 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 32 CA - CB - CG ANGL. DEV. = 14.5 DEGREES REMARK 500 TYR A 57 CB - CG - CD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 TYR A 87 CB - CG - CD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 114 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ARG A 123 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ARG A 123 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG A 134 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 ARG A 148 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 ARG A 190 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 TYR B 25 CB - CG - CD2 ANGL. DEV. = 4.2 DEGREES REMARK 500 TYR B 57 CB - CG - CD1 ANGL. DEV. = 4.7 DEGREES REMARK 500 TYR B 87 CB - CG - CD1 ANGL. DEV. = 5.2 DEGREES REMARK 500 TYR B 87 CG - CD1 - CE1 ANGL. DEV. = 5.2 DEGREES REMARK 500 ARG B 123 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 PHE B 128 CB - CG - CD1 ANGL. DEV. = 4.8 DEGREES REMARK 500 ARG B 134 CD - NE - CZ ANGL. DEV. = 11.4 DEGREES REMARK 500 ARG B 134 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ARG B 148 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG B 148 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 15 -152.95 -122.21 REMARK 500 ASP A 16 -75.99 -47.66 REMARK 500 ASN A 112 97.68 -161.60 REMARK 500 ALA A 135 60.30 -161.67 REMARK 500 ASP B 16 -72.49 -31.87 REMARK 500 PRO B 17 96.88 -68.46 REMARK 500 ASN B 112 95.14 -160.88 REMARK 500 ALA B 135 60.00 -167.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 191 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 191 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 192 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 192 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 369221 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 2PFX A 1 190 UNP Q1GDR9 Q1GDR9_SILST 1 190 DBREF 2PFX B 1 190 UNP Q1GDR9 Q1GDR9_SILST 1 190 SEQADV 2PFX GLY A 0 UNP Q1GDR9 EXPRESSION TAG SEQADV 2PFX MSE A 1 UNP Q1GDR9 MET 1 MODIFIED RESIDUE SEQADV 2PFX MSE A 14 UNP Q1GDR9 MET 14 MODIFIED RESIDUE SEQADV 2PFX MSE A 35 UNP Q1GDR9 MET 35 MODIFIED RESIDUE SEQADV 2PFX MSE A 56 UNP Q1GDR9 MET 56 MODIFIED RESIDUE SEQADV 2PFX MSE A 61 UNP Q1GDR9 MET 61 MODIFIED RESIDUE SEQADV 2PFX MSE A 74 UNP Q1GDR9 MET 74 MODIFIED RESIDUE SEQADV 2PFX MSE A 108 UNP Q1GDR9 MET 108 MODIFIED RESIDUE SEQADV 2PFX MSE A 111 UNP Q1GDR9 MET 111 MODIFIED RESIDUE SEQADV 2PFX MSE A 125 UNP Q1GDR9 MET 125 MODIFIED RESIDUE SEQADV 2PFX MSE A 132 UNP Q1GDR9 MET 132 MODIFIED RESIDUE SEQADV 2PFX MSE A 169 UNP Q1GDR9 MET 169 MODIFIED RESIDUE SEQADV 2PFX MSE A 179 UNP Q1GDR9 MET 179 MODIFIED RESIDUE SEQADV 2PFX MSE A 180 UNP Q1GDR9 MET 180 MODIFIED RESIDUE SEQADV 2PFX GLY B 0 UNP Q1GDR9 EXPRESSION TAG SEQADV 2PFX MSE B 1 UNP Q1GDR9 MET 1 MODIFIED RESIDUE SEQADV 2PFX MSE B 14 UNP Q1GDR9 MET 14 MODIFIED RESIDUE SEQADV 2PFX MSE B 35 UNP Q1GDR9 MET 35 MODIFIED RESIDUE SEQADV 2PFX MSE B 56 UNP Q1GDR9 MET 56 MODIFIED RESIDUE SEQADV 2PFX MSE B 61 UNP Q1GDR9 MET 61 MODIFIED RESIDUE SEQADV 2PFX MSE B 74 UNP Q1GDR9 MET 74 MODIFIED RESIDUE SEQADV 2PFX MSE B 108 UNP Q1GDR9 MET 108 MODIFIED RESIDUE SEQADV 2PFX MSE B 111 UNP Q1GDR9 MET 111 MODIFIED RESIDUE SEQADV 2PFX MSE B 125 UNP Q1GDR9 MET 125 MODIFIED RESIDUE SEQADV 2PFX MSE B 132 UNP Q1GDR9 MET 132 MODIFIED RESIDUE SEQADV 2PFX MSE B 169 UNP Q1GDR9 MET 169 MODIFIED RESIDUE SEQADV 2PFX MSE B 179 UNP Q1GDR9 MET 179 MODIFIED RESIDUE SEQADV 2PFX MSE B 180 UNP Q1GDR9 MET 180 MODIFIED RESIDUE SEQRES 1 A 191 GLY MSE THR LYS PRO LYS GLU PRO THR ALA LEU ASP LEU SEQRES 2 A 191 PRO MSE ALA ASP PRO LEU PRO ASP GLU THR GLN LYS TYR SEQRES 3 A 191 PHE GLU ILE CYS GLN GLU LYS LEU GLY MSE VAL PRO ASN SEQRES 4 A 191 VAL LEU LYS ALA TYR ALA PHE ASN VAL GLU LYS LEU ASN SEQRES 5 A 191 ALA PHE THR ALA MSE TYR ASN ASP LEU MSE LEU GLY GLU SEQRES 6 A 191 SER GLN LEU SER LYS LEU GLU ARG GLU MSE ILE ALA VAL SEQRES 7 A 191 VAL VAL SER SER ILE ASN LYS CYS PHE TYR CYS LEU VAL SEQRES 8 A 191 ALA HIS GLY ALA ALA VAL ARG GLN LEU SER GLY ASP PRO SEQRES 9 A 191 GLN LEU GLY GLU MSE LEU VAL MSE ASN TYR ARG VAL ALA SEQRES 10 A 191 PRO LEU ASP ALA ARG GLN ARG VAL MSE LEU ASP PHE ALA SEQRES 11 A 191 ALA LYS MSE THR ARG ALA SER ALA GLU ILE GLU GLU ALA SEQRES 12 A 191 ASP ARG GLU VAL LEU ARG SER HIS GLY PHE ASN ASP ARG SEQRES 13 A 191 ASP ILE TRP ASP ILE ALA ASN VAL THR GLY PHE PHE ASN SEQRES 14 A 191 MSE THR ASN ARG VAL ALA SER ALA THR ALA MSE MSE PRO SEQRES 15 A 191 ASN ALA GLU TYR HIS GLY GLN PHE ARG SEQRES 1 B 191 GLY MSE THR LYS PRO LYS GLU PRO THR ALA LEU ASP LEU SEQRES 2 B 191 PRO MSE ALA ASP PRO LEU PRO ASP GLU THR GLN LYS TYR SEQRES 3 B 191 PHE GLU ILE CYS GLN GLU LYS LEU GLY MSE VAL PRO ASN SEQRES 4 B 191 VAL LEU LYS ALA TYR ALA PHE ASN VAL GLU LYS LEU ASN SEQRES 5 B 191 ALA PHE THR ALA MSE TYR ASN ASP LEU MSE LEU GLY GLU SEQRES 6 B 191 SER GLN LEU SER LYS LEU GLU ARG GLU MSE ILE ALA VAL SEQRES 7 B 191 VAL VAL SER SER ILE ASN LYS CYS PHE TYR CYS LEU VAL SEQRES 8 B 191 ALA HIS GLY ALA ALA VAL ARG GLN LEU SER GLY ASP PRO SEQRES 9 B 191 GLN LEU GLY GLU MSE LEU VAL MSE ASN TYR ARG VAL ALA SEQRES 10 B 191 PRO LEU ASP ALA ARG GLN ARG VAL MSE LEU ASP PHE ALA SEQRES 11 B 191 ALA LYS MSE THR ARG ALA SER ALA GLU ILE GLU GLU ALA SEQRES 12 B 191 ASP ARG GLU VAL LEU ARG SER HIS GLY PHE ASN ASP ARG SEQRES 13 B 191 ASP ILE TRP ASP ILE ALA ASN VAL THR GLY PHE PHE ASN SEQRES 14 B 191 MSE THR ASN ARG VAL ALA SER ALA THR ALA MSE MSE PRO SEQRES 15 B 191 ASN ALA GLU TYR HIS GLY GLN PHE ARG MODRES 2PFX MSE A 1 MET SELENOMETHIONINE MODRES 2PFX MSE A 14 MET SELENOMETHIONINE MODRES 2PFX MSE A 35 MET SELENOMETHIONINE MODRES 2PFX MSE A 56 MET SELENOMETHIONINE MODRES 2PFX MSE A 61 MET SELENOMETHIONINE MODRES 2PFX MSE A 74 MET SELENOMETHIONINE MODRES 2PFX MSE A 108 MET SELENOMETHIONINE MODRES 2PFX MSE A 111 MET SELENOMETHIONINE MODRES 2PFX MSE A 125 MET SELENOMETHIONINE MODRES 2PFX MSE A 132 MET SELENOMETHIONINE MODRES 2PFX MSE A 169 MET SELENOMETHIONINE MODRES 2PFX MSE A 179 MET SELENOMETHIONINE MODRES 2PFX MSE A 180 MET SELENOMETHIONINE MODRES 2PFX MSE B 1 MET SELENOMETHIONINE MODRES 2PFX MSE B 14 MET SELENOMETHIONINE MODRES 2PFX MSE B 35 MET SELENOMETHIONINE MODRES 2PFX MSE B 56 MET SELENOMETHIONINE MODRES 2PFX MSE B 61 MET SELENOMETHIONINE MODRES 2PFX MSE B 74 MET SELENOMETHIONINE MODRES 2PFX MSE B 108 MET SELENOMETHIONINE MODRES 2PFX MSE B 111 MET SELENOMETHIONINE MODRES 2PFX MSE B 125 MET SELENOMETHIONINE MODRES 2PFX MSE B 132 MET SELENOMETHIONINE MODRES 2PFX MSE B 169 MET SELENOMETHIONINE MODRES 2PFX MSE B 179 MET SELENOMETHIONINE MODRES 2PFX MSE B 180 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 14 8 HET MSE A 35 8 HET MSE A 56 8 HET MSE A 61 8 HET MSE A 74 8 HET MSE A 108 8 HET MSE A 111 8 HET MSE A 125 8 HET MSE A 132 8 HET MSE A 169 8 HET MSE A 179 8 HET MSE A 180 16 HET MSE B 1 8 HET MSE B 14 8 HET MSE B 35 8 HET MSE B 56 8 HET MSE B 61 8 HET MSE B 74 8 HET MSE B 108 8 HET MSE B 111 8 HET MSE B 125 8 HET MSE B 132 16 HET MSE B 169 8 HET MSE B 179 8 HET MSE B 180 16 HET ACT A 191 4 HET PG4 A 192 13 HET ACT B 191 4 HET CL B 192 1 HETNAM MSE SELENOMETHIONINE HETNAM ACT ACETATE ION HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM CL CHLORIDE ION FORMUL 1 MSE 26(C5 H11 N O2 SE) FORMUL 3 ACT 2(C2 H3 O2 1-) FORMUL 4 PG4 C8 H18 O5 FORMUL 6 CL CL 1- FORMUL 7 HOH *315(H2 O) HELIX 1 1 PRO A 19 GLY A 34 1 16 HELIX 2 2 PRO A 37 ALA A 44 1 8 HELIX 3 3 ASN A 46 GLY A 63 1 18 HELIX 4 4 SER A 68 LYS A 84 1 17 HELIX 5 5 CYS A 85 GLY A 101 1 17 HELIX 6 6 ASP A 102 ASN A 112 1 11 HELIX 7 7 TYR A 113 ALA A 116 5 4 HELIX 8 8 ASP A 119 SER A 136 1 18 HELIX 9 9 ALA A 137 ILE A 139 5 3 HELIX 10 10 GLU A 140 HIS A 150 1 11 HELIX 11 11 ASN A 153 ALA A 178 1 26 HELIX 12 12 ASN A 182 GLN A 188 5 7 HELIX 13 13 PRO B 19 GLY B 34 1 16 HELIX 14 14 PRO B 37 ALA B 44 1 8 HELIX 15 15 ASN B 46 GLY B 63 1 18 HELIX 16 16 SER B 68 LYS B 84 1 17 HELIX 17 17 CYS B 85 GLY B 101 1 17 HELIX 18 18 ASP B 102 ASN B 112 1 11 HELIX 19 19 TYR B 113 ALA B 116 5 4 HELIX 20 20 ASP B 119 SER B 136 1 18 HELIX 21 21 ALA B 137 ILE B 139 5 3 HELIX 22 22 GLU B 140 SER B 149 1 10 HELIX 23 23 ASN B 153 ALA B 178 1 26 HELIX 24 24 ASN B 182 GLN B 188 5 7 LINK C GLY A 0 N MSE A 1 1555 1555 1.34 LINK C MSE A 1 N THR A 2 1555 1555 1.32 LINK C PRO A 13 N MSE A 14 1555 1555 1.33 LINK C MSE A 14 N ALA A 15 1555 1555 1.31 LINK C GLY A 34 N MSE A 35 1555 1555 1.33 LINK C MSE A 35 N VAL A 36 1555 1555 1.33 LINK C ALA A 55 N MSE A 56 1555 1555 1.33 LINK C MSE A 56 N TYR A 57 1555 1555 1.34 LINK C LEU A 60 N MSE A 61 1555 1555 1.33 LINK C MSE A 61 N LEU A 62 1555 1555 1.33 LINK C GLU A 73 N MSE A 74 1555 1555 1.33 LINK C MSE A 74 N ILE A 75 1555 1555 1.32 LINK C GLU A 107 N MSE A 108 1555 1555 1.32 LINK C MSE A 108 N LEU A 109 1555 1555 1.33 LINK C VAL A 110 N MSE A 111 1555 1555 1.33 LINK C MSE A 111 N ASN A 112 1555 1555 1.31 LINK C VAL A 124 N MSE A 125 1555 1555 1.32 LINK C MSE A 125 N LEU A 126 1555 1555 1.32 LINK C LYS A 131 N MSE A 132 1555 1555 1.32 LINK C MSE A 132 N THR A 133 1555 1555 1.33 LINK C ASN A 168 N MSE A 169 1555 1555 1.33 LINK C MSE A 169 N THR A 170 1555 1555 1.32 LINK C ALA A 178 N MSE A 179 1555 1555 1.33 LINK C MSE A 179 N AMSE A 180 1555 1555 1.34 LINK C MSE A 179 N BMSE A 180 1555 1555 1.34 LINK C BMSE A 180 N PRO A 181 1555 1555 1.33 LINK C AMSE A 180 N PRO A 181 1555 1555 1.33 LINK C GLY B 0 N MSE B 1 1555 1555 1.34 LINK C MSE B 1 N THR B 2 1555 1555 1.32 LINK C PRO B 13 N MSE B 14 1555 1555 1.33 LINK C MSE B 14 N ALA B 15 1555 1555 1.31 LINK C GLY B 34 N MSE B 35 1555 1555 1.33 LINK C MSE B 35 N VAL B 36 1555 1555 1.33 LINK C ALA B 55 N MSE B 56 1555 1555 1.33 LINK C MSE B 56 N TYR B 57 1555 1555 1.33 LINK C LEU B 60 N MSE B 61 1555 1555 1.33 LINK C MSE B 61 N LEU B 62 1555 1555 1.33 LINK C GLU B 73 N MSE B 74 1555 1555 1.34 LINK C MSE B 74 N ILE B 75 1555 1555 1.32 LINK C GLU B 107 N MSE B 108 1555 1555 1.34 LINK C MSE B 108 N LEU B 109 1555 1555 1.34 LINK C VAL B 110 N MSE B 111 1555 1555 1.33 LINK C MSE B 111 N ASN B 112 1555 1555 1.33 LINK C VAL B 124 N MSE B 125 1555 1555 1.32 LINK C MSE B 125 N LEU B 126 1555 1555 1.32 LINK C LYS B 131 N BMSE B 132 1555 1555 1.33 LINK C LYS B 131 N AMSE B 132 1555 1555 1.32 LINK C BMSE B 132 N THR B 133 1555 1555 1.33 LINK C AMSE B 132 N THR B 133 1555 1555 1.33 LINK C ASN B 168 N MSE B 169 1555 1555 1.33 LINK C MSE B 169 N THR B 170 1555 1555 1.33 LINK C ALA B 178 N MSE B 179 1555 1555 1.32 LINK C MSE B 179 N BMSE B 180 1555 1555 1.34 LINK C MSE B 179 N AMSE B 180 1555 1555 1.33 LINK C BMSE B 180 N PRO B 181 1555 1555 1.33 LINK C AMSE B 180 N PRO B 181 1555 1555 1.34 CISPEP 1 GLU A 6 PRO A 7 0 -4.94 CISPEP 2 MSE A 14 ALA A 15 0 0.10 CISPEP 3 GLU B 6 PRO B 7 0 -3.61 CISPEP 4 MSE B 14 ALA B 15 0 -4.71 SITE 1 AC1 6 SER A 149 HIS A 150 HOH A 200 HOH A 205 SITE 2 AC1 6 SER B 149 HIS B 150 SITE 1 AC2 5 LYS A 49 MSE B 56 ASP B 59 LEU B 60 SITE 2 AC2 5 HOH B 222 SITE 1 AC3 5 ARG B 97 GLY B 101 ASP B 102 PRO B 103 SITE 2 AC3 5 PHE B 189 SITE 1 AC4 10 GLU A 21 TYR A 25 ASN A 51 THR A 54 SITE 2 AC4 10 HOH A 283 ILE B 28 GLU B 31 LYS B 32 SITE 3 AC4 10 HOH B 284 HOH B 333 CRYST1 85.069 85.069 105.616 90.00 90.00 120.00 P 63 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011750 0.006790 0.000000 0.00000 SCALE2 0.000000 0.013570 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009470 0.00000